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THE TOTAL SYNTHESIS OF A CONFORMATIONALLY CONSTRAINED 
ORGANOPHOSPHORUS ANALOG OF ACETYLCHOLINE 
Dustin Mergott and Jeff Frick* 
Department of Chemistry, illinois Wesleyan University 
Acetylcholinesterase (AChE) is an important enzyme in the human nervous system. AChE 
helps nerves function by catalyzing the hydrolysis of acetylcholine (ACh) into choline and 
acetate. AChE has been targeted as having a potential role in the pathology of 
neurodegenerative diseases such as Alzheimer's disease. It is known that AChE is inhibited 
by organophosphorus compounds such as soman and sarin. Past research has focused on 
the use of different organophosphorus inhibitors to study the structure of AChE, the 
mechanism by which it catalyzes the hydrolysis of ACh, and the stereoselectivity of AChE 
phosphorylation. This research has yielded conflicting results about the stereo selectivity of 
the phosphorylation of AChE. We propose that a conformationally constrained analog of 
ACh may provide more definitive answers about the stereo selectivity of the mechanism of 
AChE phosphorylation. These answers could lead to a better understanding of how AChE 
catalysis works. We intend to synthesize a novel organophosphorus analog of ACh. Long 
term goals of the project include the synthesis of all four stereoisomers of this inhibitor 
followed by biological assays to determine the inhibitory potency of these compounds. 
